Which GLP-1 is Most Effective for Weight Loss?

Last reviewed: June 4, 2026

Last updated: June 4, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Clinical trials show semaglutide and tirzepatide produce 15–22% weight loss over 68 weeks, but individual response varies significantly based on genetics and peptide-pathway function. Choosing the right GLP-1 medication depends on your unique metabolic profile, not just the drug itself.

How Semaglutide and Tirzepatide Differ in Effectiveness

Semaglutide targets a single receptor pathway—the GLP-1 pathway—which controls appetite signaling and blood sugar regulation. Tirzepatide activates two pathways simultaneously: GLP-1 and GIP receptors, potentially triggering stronger weight loss in people whose bodies respond to dual activation. However, this doesn't mean tirzepatide is universally superior; some people lose more weight on semaglutide because their genetic profile favors GLP-1-pathway sensitivity.

Head-to-head trial data shows tirzepatide users averaged 21% weight loss compared to semaglutide's 16% at comparable dose ranges. Yet real-world outcomes often depend on whether your body's GIPR genes are optimally expressed. A person with high genetic sensitivity to GLP-1 signaling may see equivalent or better results from semaglutide at lower cost and fewer side effects.

The Role of Genetic Variation in GLP-1 Response

Your DNA contains specific genetic variants that influence how strongly you respond to GLP-1 and GIP receptor activation. The GLP1R rs6923761 variant and GIPR rs1800437 variant are two key sites that determine whether your appetite-control pathways are naturally more or less sensitive to these medications. People carrying certain alleles at these loci may lose 30% more weight on the same dose than others, simply because their receptors function more efficiently.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to GLP-1 medications or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Comparing Semaglutide, Tirzepatide, and Dual Compounds

Semaglutide injection (starting at $189/mo (or $149/mo on the 6-month plan)) is effective for most people and causes less GI side effects than tirzepatide because it activates only one pathway. Tirzepatide injection (at $289/mo month-to-month, or from $249/mo on the 6-month plan) offers stronger average weight loss but may cause nausea, vomiting, or diarrhea in roughly 1 in 4 users during dose escalation. PlexusDx also offers GLP-Squared Injection, a proprietary dual compound combining semaglutide and tirzepatide for users whose genetic profiles suggest they'll benefit from both pathways simultaneously.

Your dose may need to go up. Your price won't. All PlexusDx medications are priced per compound, not per dose level, so titrating safely without hitting price barriers is built into the service model. Whether you start on semaglutide, tirzepatide, or GLP-Squared, your monthly cost remains flat across all dose tiers.

Finding Your Most Effective GLP-1 With Genetic Insight

The most effective GLP-1 for weight loss is the one matched to your genetic predispositions and peptide-pathway sensitivity. Semaglutide works best for people with high GLP-1R function; tirzepatide excels in those with strong GIP and GLP-1 responsiveness; dual compounds suit individuals whose genetic profile favors activation of multiple pathways. Without genetic insight, selecting a medication is essentially guesswork based on average population data.

PlexusDx clinicians use Precision Peptide Genetic Test results alongside your health history to recommend the compound most likely to produce sustainable weight loss specific to your body. You begin treatment immediately and receive genetic results within 30 days of your second month, allowing your care team to optimize therapy if needed. All PlexusDx medications ship from licensed 503A compounding pharmacies to all 50 states with no insurance required.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Is tirzepatide always more effective than semaglutide for weight loss?

No. While tirzepatide produces larger average weight loss in clinical trials, semaglutide often works equally well or better for people whose genetics favor GLP-1-pathway sensitivity. The most effective medication is the one personalized to your peptide-pathway biology, not the one with the highest group average.

What percentage of weight can I expect to lose on a GLP-1 medication?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

How much does PlexusDx semaglutide cost compared to other GLP-1 providers?

PlexusDx compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) flat across all dose levels—your dose may go up, but your price won't. Medications come from licensed 503A compounding pharmacies and ship to all 50 states. HSA and FSA funds are eligible, and no insurance or membership fees apply.

Are there safety differences between semaglutide and tirzepatide?

Both are well-tolerated, but tirzepatide causes nausea and GI side effects in roughly 1 in 4 users during dose escalation because it activates two pathways simultaneously. Semaglutide generally produces fewer GI effects.

How does PlexusDx genetic testing help me choose between semaglutide and tirzepatide?

The Precision Peptide Genetic Test ($298) analyzes your GIPR variants, plus 47 other peptide-pathway genes, to describe the pathway-level variants involved.

Related Reading

• Glp 1 For Weight Loss 2
• Glp 1 Weight Loss Before And After
• Glp 1 Dosage For Weight Loss
• Glp 1 Receptor Agonist For Weight Loss

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.